Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112279765B details a novel NHC-catalyzed kinetic resolution for chiral alpha-fluoroketones, offering mild conditions and high efficiency for pharmaceutical intermediate manufacturing.
Patent CN114085219A details a high-ee synthesis of (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane. This route offers superior yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN1639172A details novel silicon-based reagents for high-ee alcohol synthesis, offering scalable routes for complex pharmaceutical intermediates manufacturing.
Patent CN116789664A details a metal-free photocatalytic route for trifluoromethyl benzimidazoloisoquinoline analogues, offering cost-effective and scalable manufacturing solutions.
Patent CN110818576B reveals a novel rare earth catalyzed synthesis of secondary amines. High yield, mild conditions, and cost-effective supply chain solutions for pharma.
Patent CN104725280B reveals ETS-10 catalyzed route for high purity diarylurea intermediates. Delivers cost effective supply chain solutions for global pharmaceutical manufacturing partners.
Advanced patent CN106478518A enables high-purity Rosuvastatin intermediate production with improved safety and scalability for global supply chains.
Novel isoxazoline preparation via Lewis acid catalysis. Mild conditions, high purity, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN111560017B reveals efficient synthesis of azabicyclo alkanone dipeptide mimetics. Discover cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN1267410C reveals a safer, high-yield route for cyclohexanol derivatives using amidine catalysts, offering significant cost reduction in API manufacturing and supply chain reliability.
Novel copper photocatalysis method enables mild nitrogen-alkylation. Reduces costs and improves supply chain reliability for complex pharmaceutical intermediate manufacturing.
Discover the novel chiral zinc-nitrogen complex from patent CN102887912A. Enhance asymmetric synthesis capabilities with our reliable supply of specialized catalytic intermediates.
Efficient rhodium-catalyzed asymmetric cyclopropanation for antiviral drug intermediates. High enantioselectivity and scalable process for pharmaceutical manufacturing.
Patent CN100579954C reveals a safer synthesis route for antidepressant intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN109734686A reveals low-cost stannous chloride catalysis for high-yield benzofuran production ensuring supply chain stability and significant cost reduction.
Novel Pauson-Khand route reduces costs and improves yield for high-purity methyl dihydrojasmonate manufacturing suitable for fragrance industry scale-up.
Patent CN101125875A reveals a novel ionic liquid method for fluticasone propionate, offering high yields and significant cost reduction in API manufacturing.
Advanced bromination route for Betamethasone acetate production. High purity, cost-effective process replacing iodine. Ideal for API manufacturers seeking stable supply.
Patent CN109705065B details a cyanide-free asymmetric synthesis of D-(-)-pantolactone using chiral phase transfer catalysis, offering high purity and scalable manufacturing for Vitamin B5 production.
Patent CN102465159A reveals a green microbial route for Eslicarbazepine. Discover cost-effective, high-purity manufacturing solutions for API intermediates.